[1]
O. Bozkurt, S. Tarik Firat, E. Dogan, R. Cosar, M. Inanc, and M. Ozkan, “The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy ”, annalsmedres, vol. 26, no. 10, pp. 2098–2104, May 2021.